Venture Certified
| 벤처투자유형 | 2020-09-24 ~ 2022-09-23 | 20200301082 | 2020-09-24 |
| 벤처투자유형 | 2022-09-24 ~ 2025-09-23 | 20220915010001 | 2020-09-24 |
| 벤처투자유형 | 2025-09-24 ~ 2028-09-23 | 20250910010012 | 2020-09-24 |
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.0B | 0.0B | 0.0B |
| Operating Profit | -130B | -116B | -99B |
| Net Profit | 8.9B | -169B | -211B |
| Total Assets | 54B | 151B | 247B |
| Total Liabilities | 549B | 678B | 617B |
| Total Equity | -495B | -527B | -370B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -130B
- 0.0%
▼ 20.6%
▲ 24.8%
▼ 104.1%
| Name | Position | Role |
|---|---|---|
| 박희동 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "서울 마포구",
"ceo_name": "박희동",
"certificate": [
{
"cert_number": "20200301082",
"changes": "",
"disclosure_date": "2020-09-24",
"first_cert_date": "2020-09-24",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2020-09-24 ~ 2022-09-23"
},
{
"cert_number": "20220915010001",
"changes": "",
"disclosure_date": "2022-09-15",
"first_cert_date": "2020-09-24",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2022-09-24 ~ 2025-09-23"
},
{
"cert_number": "20250910010012",
"changes": "",
"disclosure_date": "2025-09-10",
"first_cert_date": "2020-09-24",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2025-09-24 ~ 2028-09-23"
}
],
"company_name": "(주)이노보테라퓨틱스",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 520000000,
"cost_of_sales": 0,
"current_assets": 22247931000,
"current_liabilities": 60651331000,
"gross_profit": 0,
"net_income": -21051641000,
"net_income_bs": -21051640000,
"non_current_assets": 2462488000,
"non_current_liabilities": 1052490000,
"non_operating_expenses": 11619208000,
"non_operating_income": 483787000,
"operating_profit": -9916220000,
"revenue": 0,
"sga_expenses": 9916220000,
"total_assets": 24710419000,
"total_equity": -36993402000,
"total_liabilities": 61703821000
},
"2023": {
"capital_stock": 5200000000,
"cost_of_sales": 0,
"current_assets": 12289540000,
"current_liabilities": 66930228000,
"gross_profit": 0,
"net_income": -16936442000,
"net_income_bs": -16936442000,
"non_current_assets": 2768081000,
"non_current_liabilities": 856267000,
"non_operating_expenses": 5798323000,
"non_operating_income": 464517000,
"operating_profit": -11602636000,
"revenue": 0,
"sga_expenses": 11602636000,
"total_assets": 15057622000,
"total_equity": -52728873000,
"total_liabilities": 67786495000
},
"2024": {
"capital_stock": 5355000000,
"cost_of_sales": 0,
"current_assets": 2609943000,
"current_liabilities": 53716445000,
"gross_profit": 0,
"net_income": 894268000,
"net_income_bs": 894268000,
"non_current_assets": 2827619000,
"non_current_liabilities": 1175269000,
"non_operating_expenses": 3555934000,
"non_operating_income": 17422370000,
"operating_profit": -12972168000,
"revenue": 0,
"sga_expenses": 12972168000,
"total_assets": 5437562000,
"total_equity": -49454151000,
"total_liabilities": 54891713000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [
{
"amount": "5,000,001,100",
"changes": "5,000,001,100",
"date": "2025-03-21"
},
{
"amount": "2,001,000,000",
"changes": "2,001,000,000",
"date": "2022-01-26"
},
{
"amount": "4,000,000,000",
"changes": "4,000,000,000",
"date": "2022-01-26"
},
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2022-01-26"
},
{
"amount": "2,490,000,000",
"changes": "2,490,000,000",
"date": "2021-12-30"
},
{
"amount": "2,020,000,000",
"changes": "2,020,000,000",
"date": "2021-12-21"
},
{
"amount": "5,001,000,000",
"changes": "5,001,000,000",
"date": "2021-11-30"
},
{
"amount": "5,001,499,000",
"changes": "5,001,499,000",
"date": "2021-11-30"
},
{
"amount": "2,001,000,000",
"changes": "2,001,000,000",
"date": "2020-02-18"
},
{
"amount": "2,000,027,000",
"changes": "2,000,027,000",
"date": "2020-02-18"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2020-01-07"
},
{
"amount": "500,000,000",
"changes": "500,000,000",
"date": "2020-01-07"
},
{
"amount": "5,000,066,250",
"changes": "5,000,066,250",
"date": "2019-12-27"
},
{
"amount": "1,000,000,000",
"changes": "1,000,000,000",
"date": "2019-12-27"
}
],
"main_products": "의약품의 개발,의약품 생산/소프트웨어 개발,판매",
"phone": "02-6956-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 6/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |